Skip to main content

Aluminum in Subjects Receiving Parenteral Nutrition

  • Living reference work entry
  • First Online:
Diet and Nutrition in Critical Care
  • 132 Accesses

Abstract

Al is ubiquitous, facilitating potential exposure to this element. Nevertheless, its poor absorption via the gastrointestinal tract protects the vast majority of the population from the risk of Al loading and toxicity. However, when the protective gastrointestinal mechanism is bypassed, as occurs in parenteral nutritional therapy, Al is prone to accumulate in the body. Due to this accumulation, Al is implicated in metabolic bone disease associated with parenteral nutrition in both pediatric and adult patients. Neonates are at an increased risk of aluminum toxicity because of anatomic, physiologic, and nutrition-related factors not present in other populations. Regulatory agencies recommended restricting parenteral aluminum administration to less than 5 μg/kg/day, and the US Food and Drug Administration requires that additives used to compound parenteral nutrition (PN) have the maximum aluminum content at the date of expiration listed on the product label and that large-volume parenterals contain no more than 25 μg/L aluminum. Despite legislative efforts, some factors make it difficult to comply with this rule, and therefore, with the current products used to compound formulations for nutritional therapy, the limits are rarely achieved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

EDTA:

Ethylenediaminetetraacetic acid

FAO:

Food and Agriculture Organization

FDA:

Food and Drug Administration

IV:

Intravenous

MDI:

Mental Development Index

MHRA:

Medicine and Healthcare Products Regulatory Agency

NICU:

Neonatal intensive care unit

NOAEL:

No-observed-adverse-effect level

PN:

Parenteral nutrition

PTH:

Parathyroid hormone

PTWI:

Provisional tolerable weekly intake

TPN:

Total parenteral nutrition

WHO:

World Health Organization

References

  • Advenier E, Landry C, Colomb V, et al. Aluminum contamination of parenteral nutrition and aluminum loading in children on long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 2003;36:448–53.

    Article  CAS  PubMed  Google Scholar 

  • Alfrey AC, LeGendre GR, Kaehny WD. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976;294(4):184–8.

    Article  CAS  PubMed  Google Scholar 

  • Alfrey AC. Dialysis encephalopathy syndrome. Annu Rev Med. 1978;29:93–8.

    Article  CAS  PubMed  Google Scholar 

  • Alfrey AC. Dialysis encephalopathy. Kidney Int Suppl. 1986;18:S53–7.

    CAS  PubMed  Google Scholar 

  • Berner YN, Shuler TR, Nielsen FH, et al. Selected ultratrace elements in total parenteral nutrition solutions. Am J Clin Nutr. 1989;50(5):1079–83.

    CAS  PubMed  Google Scholar 

  • Bishop NJ, Morley R, Day JP, Lucas A. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med. 1997;336(22):1557–61.

    Article  CAS  PubMed  Google Scholar 

  • Bohrer D, Dessuy MB, Kaizer R, et al. Tissue digestion for aluminum determination in experimental animal studies. Anal Biochem. 2008;377(2):120–7.

    Article  CAS  PubMed  Google Scholar 

  • Bohrer D, do Nascimento PC, Binotto R, et al. Contribution of the raw material to the aluminum contamination in parenterals. JPEN J Parenter Enteral Nutr. 2002;26(6):382–8.

    Article  CAS  PubMed  Google Scholar 

  • Bohrer D, do Nascimento PC, Binotto R, et al. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part III: interaction container-chemicals during the heating for sterilization. J Trace Elem Med Biol. 2003;17(2):107–15.

    Article  CAS  PubMed  Google Scholar 

  • Bohrer D, Oliveira SM, Garcia SC, et al. Aluminum loading in preterm neonates revisited. J Pediatr Gastroenterol Nutr. 2010;51(2):237–41.

    Article  CAS  PubMed  Google Scholar 

  • Bougle D, Bureau F, Voirin J, et al. A cross-sectional study of plasma and urinary aluminum levels in term and preterm infants. JPEN J Parenter Enteral Nutr. 1992;16(2):157–9.

    Article  CAS  PubMed  Google Scholar 

  • Cann CE, Prussin SG, Gordan GS. Aluminum uptake by the parathyroid glands. J Clin Endocrinol Metab. 1979;49(4):543–5.

    Article  CAS  PubMed  Google Scholar 

  • Committee on Nutrition. American Academy of Pediatrics. Aluminum toxicity in infants and children. Pediatrics. 1986;78:1150–4.

    Google Scholar 

  • Committee on Nutrition. American Academy of Pediatrics. Aluminum toxicity in infants and children. Pediatrics. 1996;97:413–16.

    Google Scholar 

  • Committee on Nutrition. American Academy of Pediatrics. Aluminum toxicity in infants and children. Pediatrics. 2004;114:26.

    Google Scholar 

  • de Oliveira SR, Bohrer D, Garcia SC, et al. Aluminum content in intravenous solutions for administration to neonates: role of product preparation and administration methods. JPEN J Parenter Enteral Nutr. 2010;34(3):322–8.

    Article  PubMed  Google Scholar 

  • Department of Health and Human Services, Food and Drug Administration. Parenteral drug products containing aluminum as an ingredient or a contaminant: notice of intent and request for information. Fed Regist. 1990;55:20799–802.

    Google Scholar 

  • Department of Health and Human Services, Food and Drug Administration. Amendment of regulations on parenteral nutrition; delay of effective date. Fed Regist. 2003;68:32979–81.

    Google Scholar 

  • European Food Safety Authority. Safety of aluminium from dietary intake – scientific opinion of the panel on food additives, flavourings, processing aids and food contact materials (AFC). The EFSA Journal. 2008;754:1–88.

    Google Scholar 

  • Fernández-Martín JL, Menéndez-Fraga P, Canteros MA, et al. Binding of aluminium to plasma proteins: comparative effect of desferrioxamine and deferiprone (L1). Clin Chim Acta. 1994;230(2):137–45.

    Article  PubMed  Google Scholar 

  • Ferrone M, Geraci M. A review of the relationship between parenteral nutrition and metabolic bone disease. Nutr Clin Pract. 2007;22(3):329–39.

    Article  PubMed  Google Scholar 

  • Fewtrell MS, Edmonds CJ, Isaacs E, et al. Aluminium exposure from parenteral nutrition in preterm infants and later health outcomes during childhood and adolescence. Proc Nutr Soc. 2011;70(3):299–304.

    Article  CAS  PubMed  Google Scholar 

  • Frank EL, Hughes MP, Bankson DD, et al. Effects of anticoagulants and contemporary blood collection containers on aluminum, copper, and zinc results. Clin Chem. 2001;47(6):1109–12.

    CAS  PubMed  Google Scholar 

  • Garcia SC, Gioda A, Bohrer D. The problem of contamination in aluminum trace analysis. Quim Nova. 1997;20(4):1–5.

    Article  Google Scholar 

  • Harigaya K, Kuwahara Y, Nishi H. Determination of aluminum in large volume parenteral drug products used in total parenteral nutrition therapy by ICP-MS with a dynamic reaction cell. Chem Pharm Bull (Tokyo). 2008;56(4):475–9.

    Article  CAS  Google Scholar 

  • Hellström HO, Mjöberg B, Mallmin H, et al. The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls. Osteoporos Int. 2005;16(12):1982–8.

    Article  PubMed  Google Scholar 

  • Heyman MB, Klein GL, Wong A, et al. Aluminum does not accumulate in teenage and adult patients receiving total parenteral nutrition containing amino acids. JPEN J Parenter Enteral Nutr. 1986;10(1):86–7.

    Article  CAS  PubMed  Google Scholar 

  • Joint FAO/WHO Expert Committee on Food Additives. Seventy-fourth meeting. Summary and conclusions, Rome. 2011. ftp://ftp.fao.org/ag/agn/%E2%80%A6/JECFA_74_Summary_Report_4July2011.pdf. Accessed 15 May 2013.

  • Klein GL, Ament ME, Coburn JW. Metabolic bone disease in total parenteral nutrition. Lancet. 1981a;1(8224):835.

    Article  CAS  PubMed  Google Scholar 

  • Klein GL, Coburn JW. Total parenteral-nutrition and its effects on bone metabolism. Crit Rev Clin Lab Sci. 1994;31(2):135–67.

    Article  CAS  PubMed  Google Scholar 

  • Klein GL, Horst RL, Norman AW, et al. Reduced serum levels of 1-alpha, 25-dihydroxyvitamin D during long-term parenteral nutrition. Ann Intern Med. 1981b;94(5):638–43.

    Article  CAS  PubMed  Google Scholar 

  • Klein GL, Leichtner AM, Heyman MB. The Patient Care Committee of the North American Society for Pediatric Gastroenterology and Nutrition: aluminum in large and small volume parenterals used in total parenteral nutrition: response to the Food and Drug Administration notice of proposed rule by the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 1998;27:457–60.

    Article  CAS  PubMed  Google Scholar 

  • Klein GL. Aluminum contamination of parenteral nutrition solutions and its impact on the pediatric patient. Nutr Clin Pract. 2003;18(4):302–7.

    Article  PubMed  Google Scholar 

  • Koo WW, Kaplan LA, Bendon R, et al. Response to aluminum in parenteral nutrition during infancy. J Pediatr. 1986;109(5):877–83.

    Article  CAS  PubMed  Google Scholar 

  • Koo WW, Kaplan LA, Krug-Wispe SK, et al. Response of preterm infants to aluminum in parenteral nutrition. JPEN J Parenter Enteral Nutr. 1989;13(5):516–19.

    Article  CAS  PubMed  Google Scholar 

  • Medicines and Healthcare products Regulatory Agency- MHRA (UK). Calcium gluconate 10 % in 10 mL glass containers: risk of aluminium exposure. Public assessment report, Sept 2010.

    Google Scholar 

  • Moreno A, Domínguez C, Ballabriga A. Aluminum in the neonate related to parenteral nutrition. Acta Paediatr. 1994;83(1):25–9.

    Article  CAS  PubMed  Google Scholar 

  • Morrissey J, Rothstein M, Mayor G, et al. Suppression of parathyroid hormone secretion by aluminum. Kidney Int. 1983;23(5):699–704.

    Article  CAS  PubMed  Google Scholar 

  • Ogasawara Y, Sakamoto T, Ishii K, et al. Effects of the administration routes and chemical forms of aluminum on aluminum accumulation in rat brain. Biol Trace Elem Res. 2002;86(3):269–78.

    Article  CAS  PubMed  Google Scholar 

  • Ott SM, Maloney NA, Coburn JW, et al. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med. 1982;307(12):709–13.

    Article  CAS  PubMed  Google Scholar 

  • Ott SM, Maloney NA, Klein GL, et al. Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med. 1983;98:910–14.

    Article  CAS  PubMed  Google Scholar 

  • Poole RL, Pieroni KP, Gaskari S, et al. Aluminum in pediatric parenteral nutrition products: measured versus labeled content. J Pediatr Pharmacol Ther. 2011;16(2):92–7.

    PubMed Central  PubMed  Google Scholar 

  • Poole RL, Hintz SR, Mackenzie NI, et al. Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation. JPEN J Parenter Enteral Nutr. 2008;32:242–6.

    Article  CAS  PubMed  Google Scholar 

  • Sánchez-Iglesias S, Soto-Otero R, Iglesias-González J, et al. Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administration. J Trace Elem Med Biol. 2007;21:31–4.

    Article  PubMed  Google Scholar 

  • Sedman AB, Klein GL, Merritt RJ, et al. Evidence of aluminum loading in infants receiving intravenous therapy. N Engl J Med. 1985;312(21):1337–43.

    Article  CAS  PubMed  Google Scholar 

  • Smith BS, Kothari H, Hayes BD, et al. Effect of additive selection on calculated aluminum content of parenteral nutrient solutions. Am J Health Syst Pharm. 2007;64(7):730–9.

    Article  CAS  PubMed  Google Scholar 

  • The American Society for Clinical Nutrition/American Society for Parenteral and Enteral Nutrition Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions. Parenteral drug products containing aluminum as an ingredient or a contaminant: Response to Food and Drug Administration notice of intent and request for information. Am J Clin Nutr. 1991;53:399–402.

    Google Scholar 

  • Tomljenovic L. Aluminum and Alzheimer’s disease: after a century of controversy, is there a plausible link? J Alzheimers Dis. 2011;23(4):567–98.

    CAS  PubMed  Google Scholar 

  • US FDA Department of Health and Human Services, Food and Drug Administration. Aluminum in large and small volume parenterals used in total parenteral nutrition: title 21, vol 4, Revised as of 1 April 2013.

    Google Scholar 

  • Vargas JH, Klein GL, Ament ME, et al. Metabolic bone disease of total parenteral nutrition course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr. 1988;48(4):1070–8.

    CAS  PubMed  Google Scholar 

  • WHO. Food additives series 65: safety evaluation of certain food additives and contaminants. Geneva: World Health Organization; 2011.

    Google Scholar 

  • Wilhelm M, Hoelzer J, Luebbers K, et al. Aluminum balance in intensive care patients. J Trace Elem Med Biol. 2001;14(4):223–7.

    Article  CAS  PubMed  Google Scholar 

  • Zhou Y, Harris WR, Yokel RA. The influence of citrate, maltolate and fluoride on the gastrointestinal absorption of aluminum at a drinking water-relevant concentration: A 26Al and 14C study. J Inorg Biochem. 2008;102(4):789–808.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Denise Bohrer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Bohrer, D. (2014). Aluminum in Subjects Receiving Parenteral Nutrition. In: Rajendram, R., Preedy, V., Patel, V. (eds) Diet and Nutrition in Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8503-2_77-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8503-2_77-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-8503-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics